Literature DB >> 4714571

Social costs of Parkinson's disease.

E Singer.   

Abstract

Entities:  

Mesh：

Year:  1973        PMID： 4714571     DOI： 10.1016/0021-9681(73)90105-7

Source DB:  PubMed          Journal:  J Chronic Dis        ISSN： 0021-9681


× No keyword cloud information.
  15 in total

Review 1.  Health-related quality of life and healthcare utilisation in patients with Parkinson's disease: impact of motor fluctuations and dyskinesias.

Authors:  R C Dodel; K Berger; W H Oertel
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

2.  The economic impact of Parkinson's disease. An estimation based on a 3-month prospective analysis.

Authors:  R C Dodel; M Singer; R Köhne-Volland; T Szucs; B Rathay; E Scholz; W H Oertel
Journal:  Pharmacoeconomics       Date:  1998-09       Impact factor: 4.981

3.  Apathy in Parkinson's disease.

Authors:  G C Pluck; R G Brown
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-12       Impact factor: 10.154

4.  Cost of illness and disease severity in a cohort of French patients with Parkinson's disease.

Authors:  C LePen; S Wait; F Moutard-Martin; M Dujardin; M Ziégler
Journal:  Pharmacoeconomics       Date:  1999-07       Impact factor: 4.981

5.  Cost of illness and its predictors for Parkinson's disease in Germany.

Authors:  Annika E Spottke; Martin Reuter; Olaf Machat; Bernhard Bornschein; Sonja von Campenhausen; Karin Berger; Rudolf Koehne-Volland; Jürgen Rieke; Alexander Simonow; Dirk Brandstaedter; Uwe Siebert; Wolfgang H Oertel; Gudrun Ulm; Richard Dodel
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

Review 6.  Economic and health-related quality of life considerations of new therapies in Parkinson's disease.

Authors:  L M Rubenstein; A DeLeo; E A Chrischilles
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

7.  The impact of Parkinson's disease on health status, health expenditures, and productivity. Estimates from the National Medical Expenditure Survey.

Authors:  L M Rubenstein; E A Chrischilles; M D Voelker
Journal:  Pharmacoeconomics       Date:  1997-10       Impact factor: 4.981

8.  The health-related, social, and economic consequences of parkinsonism: a controlled national study.

Authors:  Poul Jennum; Marielle Zoetmulder; Lise Korbo; Jakob Kjellberg
Journal:  J Neurol       Date:  2011-03-11       Impact factor: 4.849

9.  Social role functioning in Parkinson's disease: A mixed-methods systematic review.

Authors:  Kate Perepezko; Jared T Hinkle; Melissa D Shepard; Nicole Fischer; Martinus P G Broen; Albert F G Leentjens; Joseph J Gallo; Gregory M Pontone
Journal:  Int J Geriatr Psychiatry       Date:  2019-05-20       Impact factor: 3.485

10.  The development and validation of a short measure of functioning and well being for individuals with Parkinson's disease.

Authors:  V Peto; C Jenkinson; R Fitzpatrick; R Greenhall
Journal:  Qual Life Res       Date:  1995-06       Impact factor: 4.147
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.